Adjuvant Intensity Modulated Whole-Abdominal Radiation Therapy for High-Risk Patients With Ovarian Cancer (International Federation of Gynecology and Obstetrics Stage III): First Results of a Prospective Phase 2 Study

Arians Nathalie; Kieser Meinhard; Benner Laura; Rochet Nathalie; Katayama Sonja; Sterzing Florian; Herfarth Klaus; Schubert Kai; Schroeder Lars; Leitzen Christina; Schneeweiss Andreas; Sohn Christof; Debus Juergen; Lindel Katja

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Adjuvant Intensity Modulated Whole-Abdominal Radiation Therapy for High-Risk Patients With Ovarian Cancer (International Federation of Gynecology and Obstetrics Stage III): First Results of a Prospective Phase 2 Study

【24h】

Adjuvant Intensity Modulated Whole-Abdominal Radiation Therapy for High-Risk Patients With Ovarian Cancer (International Federation of Gynecology and Obstetrics Stage III): First Results of a Prospective Phase 2 Study

机译：佐剂强度调节卵巢癌的高危患者的全腹部放射治疗（国际妇科和妇产科第三阶段）：前瞻性第2期研究结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To assess treatment tolerance and toxicity rates of consolidative whole-abdominal radiation therapy (WART) following cytoreductive surgery and carboplatin/ paclitaxel chemotherapy in high-risk patients with advanced ovarian cancer (International Federation of Gynecology and Obstetrics stage III) using intensity modulated radiation therapy.

机译：目的：利用强度调制辐射评估在高危卵巢癌症（国际妇科和妇产病学阶段III）的高危患者中的巩固全腹部放射治疗（疣）治疗耐受性耐受性和毒性率（疣）的治疗耐受性和毒性/紫杉醇化疗治疗。

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics》 |2017年第4期|共9页
作者
Arians Nathalie; Kieser Meinhard; Benner Laura; Rochet Nathalie; Katayama Sonja; Sterzing Florian; Herfarth Klaus; Schubert Kai; Schroeder Lars; Leitzen Christina; Schneeweiss Andreas; Sohn Christof; Debus Juergen; Lindel Katja;
展开▼
作者单位

Univ Hosp Heidelberg Natl Ctr Radiat Oncol Heidelberg Inst Radiat Oncol Heidelberg Germany;

Heidelberg Univ Inst Med Biometry &

Informat Heidelberg Germany;

Heidelberg Univ Inst Med Biometry &

Informat Heidelberg Germany;

Univ Hosp Heidelberg Natl Ctr Radiat Oncol Heidelberg Inst Radiat Oncol Heidelberg Germany;

Univ Hosp Heidelberg Natl Ctr Radiat Oncol Heidelberg Inst Radiat Oncol Heidelberg Germany;

Univ Hosp Heidelberg Natl Ctr Radiat Oncol Heidelberg Inst Radiat Oncol Heidelberg Germany;

Univ Hosp Heidelberg Natl Ctr Radiat Oncol Heidelberg Inst Radiat Oncol Heidelberg Germany;

Univ Hosp Heidelberg Natl Ctr Radiat Oncol Heidelberg Inst Radiat Oncol Heidelberg Germany;

CIO Dept Gynecol &

Obstet Cologne Germany;

Univ Hosp Bonn Dept Radiat Oncol Bonn Germany;

Univ Hosp Heidelberg Dept Gynecol &

Obstet Heidelberg Germany;

Univ Hosp Heidelberg Dept Gynecol &

Obstet Heidelberg Germany;

Univ Hosp Heidelberg Natl Ctr Radiat Oncol Heidelberg Inst Radiat Oncol Heidelberg Germany;

Univ Hosp Heidelberg Natl Ctr Radiat Oncol Heidelberg Inst Radiat Oncol Heidelberg Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
专利

1. Adjuvant Intensity Modulated Whole-Abdominal Radiation Therapy for High-Risk Patients With Ovarian Cancer (International Federation of Gynecology and Obstetrics Stage III): First Results of a Prospective Phase 2 Study [J] . Arians Nathalie, Kieser Meinhard, Benner Laura, International Journal of Radiation Oncology, Biology, Physics . 2017,第4期

机译：佐剂强度调节卵巢癌的高危患者的全腹部放射治疗（国际妇科和妇产科第三阶段）：前瞻性第2期研究结果
2. Consolidating Whole Abdomen Irradiation using intensity modulated Radiation Therapy (IMRT) in High-risk Patients with Ovarian Cancer in the FIGO III Stage - Final Results of a Phase II Study [J] . Arians N., Kieser M., Benner L., Strahlentherapie und Onkologie . 2019,第Suppla1期

机译：在FIGO III阶段使用强度调制的放射治疗（IMRT）在高危患者中使用强度调制的放射治疗（IMRT）巩固整个腹部辐照 - II期研究的最终结果
3. Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol [J] . Nathalie Rochet, Alexandra D Jensen, Florian Sterzing, BMC Cancer . 2007,第1期

机译：辅助全腹调强放疗（IMRT）用于高危期FIGO III卵巢癌患者（OVAR-IMRT-01）– I / II期研究的试验性研究：研究方案
4. Adjuvant Chemotherapy Should Not Routinely Be Recommended to Patients with Stage II Colon Cancers that Manifest Microsatellite Instability [C] . Sigurdis Haraldsdottir, Richard M. Goldberg Gastrointestinal Cancers Symposium . 2014

机译：不应常规向患有阶段结肠癌的患者常规的辅助化学疗法，表明微卫星不稳定性
5. Development of adaptive dose constraints templates for dose optimization in intensity-modulated radiation therapy (IMRT) treatment planning advanced-stage nasopharyngeal cancer. [D] . Chau, Ming Chun. 2007

机译：自适应剂量约束模板的开发，用于在强度调制放射治疗（IMRT）治疗计划晚期鼻咽癌中优化剂量。
6. Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study [O] . Nathalie Arians, Meinhard Kieser, Laura Benner, 2019

机译：卵巢癌高危患者辅助强度调制全腹放射治疗FIGO III期：前瞻性2期研究的最终结果
7. Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol [O] . 2007

机译：高危期FIGO III卵巢癌患者的辅助全腹强度调强放疗（IMRT）（OVAR-IMRT-01）– I / II期研究的先导试验：研究方案

Adjuvant Intensity Modulated Whole-Abdominal Radiation Therapy for High-Risk Patients With Ovarian Cancer (International Federation of Gynecology and Obstetrics Stage III): First Results of a Prospective Phase 2 Study

摘要

著录项

相似文献

相关主题

期刊订阅